Alnylam Pharmaceuticals Inc (ALNY) — Working Capital to Net Assets Ratio

Latest as of December 2025: 327.5%

Alnylam Pharmaceuticals Inc (ALNY) has a Working Capital to Net Assets ratio of 327.5% as of December 2025. Working capital of $2.58 Billion (current assets of $4.05 Billion minus current liabilities of $1.47 Billion) is measured against net assets of $789.18 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Alnylam Pharmaceuticals Inc to measure how much of total assets are equity-financed.

WC/NA Ratio

327.5%
Working Capital / Net Assets

Working Capital

$2.58 Billion
USD

Current Assets

$4.05 Billion
USD

Current Liabilities

$1.47 Billion
USD

Alnylam Pharmaceuticals Inc Working Capital to Net Assets (2002–2025)

This chart shows how Alnylam Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the ratio stands at 327.5%, reflecting working capital of $2.58 Billion against net assets of $789.18 Million USD. Check Alnylam Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for Alnylam Pharmaceuticals Inc (2002–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for Alnylam Pharmaceuticals Inc from 2002 to 2025, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Alnylam Pharmaceuticals Inc (ALNY) market capitalisation.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 327.5% $2.58 Billion $789.18 Million $4.05 Billion $1.47 Billion ▼ -2816.2 pp
2024 3143.7% $2.11 Billion $67.09 Million $3.30 Billion $1.19 Billion ▲ +4056.8 pp
2023 -913.2% $2.01 Billion $-220.64 Million $2.98 Billion $967.79 Million ▲ +303.0 pp
2022 -1216.2% $1.92 Billion $-158.22 Million $2.69 Billion $767.91 Million ▼ -1575.4 pp
2021 359.2% $2.11 Billion $588.20 Million $2.81 Billion $695.71 Million ▲ +159.5 pp
2020 199.7% $2.03 Billion $1.02 Billion $2.61 Billion $585.27 Million ▲ +104.9 pp
2019 94.8% $1.36 Billion $1.44 Billion $1.72 Billion $352.59 Million ▲ +20.5 pp
2018 74.2% $966.48 Million $1.30 Billion $1.21 Billion $242.84 Million ▼ -15.5 pp
2017 89.7% $1.58 Billion $1.77 Billion $1.78 Billion $198.30 Million ▲ +3.1 pp
2016 86.6% $796.65 Million $920.22 Million $989.24 Million $192.59 Million ▲ +4.1 pp
2015 82.5% $1.04 Billion $1.26 Billion $1.11 Billion $62.10 Million ▲ +13.0 pp
2014 69.5% $651.03 Million $936.27 Million $746.37 Million $95.33 Million ▼ -4.5 pp
2013 74.0% $200.16 Million $270.35 Million $254.03 Million $53.86 Million ▲ +16.4 pp
2012 57.6% $77.21 Million $134.05 Million $125.56 Million $48.34 Million ▼ -152.8 pp
2011 210.4% $248.29 Million $118.00 Million $266.44 Million $18.14 Million ▲ +122.3 pp
2010 88.1% $139.38 Million $158.23 Million $370.91 Million $231.54 Million ▼ -14.6 pp
2009 102.7% $182.80 Million $177.97 Million $293.53 Million $110.73 Million ▼ -67.3 pp
2008 170.0% $343.67 Million $202.12 Million $443.12 Million $99.45 Million ▲ +12.2 pp
2007 157.9% $314.43 Million $199.17 Million $397.90 Million $83.48 Million ▲ +58.5 pp
2006 99.3% $199.86 Million $201.17 Million $222.78 Million $22.93 Million ▼ -4.1 pp
2005 103.5% $63.93 Million $61.78 Million $82.41 Million $18.48 Million ▲ +13.3 pp
2004 90.2% $41.61 Million $46.14 Million $48.18 Million $6.58 Million ▲ +166.3 pp
2003 -76.2% $20.34 Million $-26.71 Million $24.19 Million $3.84 Million ▲ +200.3 pp
2002 -276.5% $12.85 Million $-4.65 Million $15.52 Million $2.67 Million
pp = percentage points